Adaptimmune Therapeutics - 54 Year Dividend History | ADAP
Historical dividend payout and yield for Adaptimmune Therapeutics (ADAP) since 1971. The current TTM dividend payout for Adaptimmune Therapeutics (ADAP) as of February 21, 2025 is $0.00. The current dividend yield for Adaptimmune Therapeutics as of February 21, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.148B |
$0.060B |
|
Adaptimmune Therapeutics plc is a biopharmaceutical company. The Company is focused on cancer immunotherapy products based on T-cell receptor platform. Adaptimmune Therapeutics plc is based in Abingdon, United Kingdom.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
